Symbol
VRDN on Nasdaq
Investment type
Equity - Shares of Stock
Class
Common Stock, $0.01 par value per share
Latest Disclosed Ownership
3.58M shares
Security Ownership
4.5%

Venrock Healthcare Capital Partners III, L.P. ownership in Viridian Therapeutics, Inc.DE Common Stock, $0.01 par value per share (VRDN)

2025-02-14 - Venrock Healthcare Capital Partners III, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3.58M shares of Viridian Therapeutics, Inc.DE Common Stock, $0.01 par value per share (VRDN). This represents 4.5% percent ownership of the company.